Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PP405 in Adult Males With Androgenetic Alopecia
NCT07819435Phase 3Recruiting
- Sponsor
- Pelage Pharmaceuticals
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 2
01
Overview
A Phase 3 trial of PP405 topical vehicle gel in androgenetic alopecia (AGA), sponsored by Pelage Pharmaceuticals. Started Sep 2026; status: recruiting.
02
Drugs
PP405 topical vehicle gel
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07819435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07819435.